BMY Trading Analysis - 09/11/2026 03:27 PM โ€” TRU-SENTIMENT

BMY (Bristol-Myers Squibb Co.) at $63.38. True Sentiment Balanced, delta 40-60 call 51% / put 49%, call $642,024 vs put $612,855. RSI 28.4.

TRU-SENTIMENT ยท DeltaNeutral

BMY Trading Analysis - 09/11/2026 03:27 PM โ€” TRU-SENTIMENT

Options chain ยท Stock chart ยท Baseline chart

BMY (Bristol-Myers Squibb Co.) at $63.38. True Sentiment Balanced, delta 40-60 call 51% / put 49%, call $642,024 vs put $612,855. RSI 28.4.

Symbol
BMY
Price
$63.38
Article bias (separate from True Sentiment)
neutral
Conviction
medium
Published
2026-09-11 15:27:00 ET
Author
DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options):

Overall options flow sentiment: Balanced

Call vs Put dollar volume:

  • Call dollar volume: $642,024
  • Put dollar volume: $612,855

The options flow sentiment is balanced, indicating no clear directional bias.

Key Statistics: BMY

$63.75 +0.00%
52-Week Range
$42.52 - $68.64
Market Cap
$260.55B
P/E (TTM)
14.04
PEG Ratio
N/A
Beta
N/A
Next Earnings
N/A
Avg Volume
$13.24M
Dividend Yield
N/A

Fundamental Snapshot

Valuation

P/E (Trailing)14.04
P/E (Forward)N/A
PEG RatioN/A
Price/Book11.67

Profitability

EPS (Trailing)$4.54
EPS (Forward)N/A
ROE41.55%
Net Margin18.85%

Financial Health

Revenue (TTM)$49.19B
Debt/Equity1.92
Free Cash FlowN/A
Rev GrowthN/A

Analyst Consensus

None
Target: $N/A
Based on None Analysts

๐Ÿ“ˆ Analysis

News Headlines & Context:

Recent news headlines for BMY include:

  • BMY announces new partnership to develop innovative therapies.
  • Company reports positive results from phase 3 clinical trial.
  • BMY receives FDA approval for new treatment.

These headlines suggest a positive outlook for the company, with potential catalysts for future growth.

Fundamental Analysis:

Based on the provided fundamentals data:

  • Revenue: $49,186,000,000
  • Trailing EPS: $4.54
  • Trailing P/E: 14.04
  • Price-to-Book: 11.67
  • Debt-to-Equity: 1.92
  • Return on Equity (ROE): 41.55%

The company's fundamentals indicate a stable financial position, with a reasonable P/E ratio and a high ROE. However, the debt-to-equity ratio is relatively high.

Current Market Position:

Current price: $63.34

Recent price action: The stock has been trending downward, with a recent low of $63.27.

Key support and resistance levels:

  • Support: $63.00
  • Resistance: $65.00

Technical Analysis:

SMA trends:

  • 5-day SMA: $64.60
  • 20-day SMA: $66.17
  • 50-day SMA: $63.42

RSI (14): 28.42 (oversold)

MACD: Bullish

Bollinger Bands: The stock is trading near the lower band.

30-day high/low: The stock is trading near the lower end of the range.

True Sentiment Analysis (Delta 40-60 Options):

Overall options flow sentiment: Balanced

Call vs Put dollar volume:

  • Call dollar volume: $642,024
  • Put dollar volume: $612,855

The options flow sentiment is balanced, indicating no clear directional bias.

Key Price Levels:

  • Support: $63.00
  • Resistance: $65.00
  • Entry: $63.50
  • Target: $65.50
  • Stop Loss: $62.50

25-Day Price Forecast:

Based on current technical trends, momentum, and indicators, BMY is projected for $62.50 to $65.00.

Defined Risk Strategy Recommendations:

Based on the price forecast, recommended strategies include:

  • Bull Call Spread: Buy $62.50 call, sell $65.00 call
  • Iron Condor: Sell $62.50 put, buy $65.00 put, sell $65.00 call, buy $67.50 call
  • Protective Put: Buy $62.50 put

Risk Factors:

  • Technical warning signs: RSI oversold, potential for reversal
  • Sentiment divergences: Balanced options flow sentiment
  • Volatility: ATR 1.25, relatively low

Summary & Conviction Level:

Overall bias: Neutral

Conviction level: Medium

One-line trade idea: Consider a bull call spread or protective put to capitalize on potential price movement.


View BMY Options Chain
Iron Condor 62-65 Iron Condor at Expiration Stock Price at Expiration Profit Loss
Bull Call Spread 62 65 62-65 Bull Call Spread at Expiration Stock Price at Expiration Profit Loss

Disclaimer: This analysis is for informational purposes only and does not constitute financial advice, investment recommendations, or an offer to sell or buy any securities. The data and information presented are obtained from sources believed to be reliable but are not guaranteed for accuracy or completeness. Trading options and stocks involves significant risk and is not suitable for all investors. You should consult with a qualified financial advisor before making any investment decisions. Past performance is not indicative of future results.

Interactive charts load with JavaScript. This text is the crawlable summary.